REG - Edita Food Ind SAE - Edita Board Resolutions Dated March 13, 2025

Edita Food Industries SAEAnnouncement

13/03/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250313:nRSM5313Aa&default-theme=true

RNS Number : 5313A  Edita Food Industries S.A.E.  13 March 2025

 

Edita Food Industries - Summary of Resolutions of the Board of Directors
Meeting of the company convened on Wednesday 12 March 2025

 

Giza, 12 March 2025

 

Edita Food Industries S.A.E. ("the Company") announces that the Board of
Directors Meeting No. (197) of the Company convened on Wednesday dated 12
March 2025 and unanimously resolved the following resolutions:

 1)    Approval of the minutes of the previous Board of Directors Meeting
 (No. 196) dated 9/3/2025.

 2)    Approval to call for an Extraordinary general assembly meeting
 ("EGM") and delegating the Chairman of the company in determining the place
 and method of convening the meeting and amending the date of meeting, as the
 case may be, to consider the following agenda:

 1.     Consider approving to increase the capital of the company from EGP
 140,002,731.2 (one hundred forty million two thousand seven hundred thirty-one
 Egyptian pounds and twenty piasters) to EGP 280,005,462.4 (two hundred eighty
 million five thousand four hundred and sixty two Egyptian pounds and forty
 piasters) with  an increase amounting to EGP 140,002,731.2 (one hundred forty
 million two thousand seven hundred thirty-one Egyptian pounds and twenty
 piasters) allocated on 700,013,656 shares with nominal value of 0.20 piasters
 each - to be financed from retained earnings pursuant  to the financial
 statements of the fiscal year ending on 31/12/2023 and certified by virtue of
 the ordinary general assembly meeting dated 28 March 2024.

 2.     Consider approving the amendment of Article (6) and (7) of the
 articles of association of the Company.

 3.     Consider approving the amendment of Article (21) of the articles of
 association of the Company.

 4.     Consider approving the amendment of Article (24) of the articles of
 association of the Company.

 5.     Consider approving the amendment of Article (31) of the articles of
 association of the Company.

 6.     Consider approving the amendment of Article (32) of the articles of
 association of the Company.

 7.     Consider approving the amendment of Article (46) of the articles of
 association of the Company.

 3)    Approval of the ratification of the disclosure report pursuant to
 Article (48) of the EGX listing rules for the purpose of proceeding with the
 capital increase of the company, obtaining the FRA approval on same and
 convening the EGM.

 4)    Approval of the delegation of the Chairman or whoever he delegates to
 submit to the Financial Regulatory Authority the disclosure report pursuant to
 Article (48) of the EGX listing rules and insert amendments that may be
 required by FRA.

 5)    Approval of the delegation of the Company's Chairman to undertake the
 procedures of calling the Extraordinary General Meeting within one week from
 publishing the disclosure report on the EGX trading screens.

 

-Ends

Contacts

Ms. Menna Shams El Din

Chief Investment Officer & Corporate Affairs

T: +202 3851 6464 | M: +20 100 1542428 |  menna.shamseldin@edita.com.eg
(mailto:%20menna.shamseldin@edita.com.eg)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMPKNBKABKKFND